Aug 10, 2021 7:11am EDT IMV Announces Final Topline Results of the DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer
Aug 02, 2021 7:05am EDT IMV Inc. to Announce Second Quarter 2021 Results and Host a Conference Call and Webcast on August 11, 2021
Jul 14, 2021 4:05pm EDT IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Units
Jun 09, 2021 7:05am EDT IMV Announces Appointment of Jeremy R. Graff, Ph.D. as Chief Scientific Officer And Addition of Clinical Advisor
Jun 08, 2021 7:05am EDT Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting
